PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 28, 2026Neurosymbolic Artificial Intelligence0 citations

Knowledge Graphs and Explainable Artificial Intelligence (AI) for Drug Repurposing on Rare Diseases

View Full Paper
PPPablo Perdomo-QuinteiroKWKatherine WolstencroftMRMarco Roos

Key Points

  • The study aims to enhance drug repurposing for rare diseases by providing understandable explanations for AI predictions.
  • Developed rd-explainer, a novel AI method using graph neural networks to identify drug candidates.
  • Integrated a knowledge graph with information on rare diseases and biomedical entities for feature learning.
  • Utilized explainable AI techniques to generate understandable semantic graphs explaining predictions.
  • Demonstrated superior performance of rd-explainer compared to state-of-the-art models.
  • Showed that the method successfully identifies plausible drug candidates with testable explanations.

Abstract

Artificial intelligence (AI)-based drug repurposing is an emerging strategy to identify drug candidates to treat rare diseases. However, cutting-edge algorithms based on deep learning typically do not provide a human understandable explanation supporting their predictions. This is a problem because it hampers biologists’ ability to decide which predictions are the most plausible drug candidates to test in costly lab experiments. In this study, we propose rd-explainer a novel AI drug repurposing method for rare diseases which obtains possible drug candidates together with human understandable explanations. The method is based on graph neural network technology and explanations were generated as semantic graphs using state-of-the-art explainable AI (XAI). The model learns features from current background knowledge on the target rare disease structured as a knowledge graph, which integrates curated facts and their evidence on different biomedical entities such as symptoms, drugs, genes, and ortholog genes. Our experiments demonstrate that our method has excellent performance that is superior to state-of-the-art models. We investigated the application of XAI on drug repurposing for rare diseases and we prove our method is capable of discovering plausible drug candidates based on testable explanations.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Perdomo-Quinteiro et al. (2026) studied this question.

synapsesocial.com/papers/69f04e7d727298f751e7276fhttps://doi.org/10.1177/29498732261443101
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Rewarding Explainability in Drug Repurposing with Knowledge Graphs2025
  2. 2Generating explainable hypotheses for drug repurposing with graph neural networks2026
  3. 3Using Extraction and Evaluation of Explanations for Drug-Repurposing on Knowledge Graphs2026
  4. 4The use of knowledge graphs for drug repurposing: From classical machine learning algorithms to graph neural networks2025
  5. 5Identifying drug repurposing candidates for rare neuro-muscular disorders, using different AI methods on the literature knowledge graph2026